Sponsored Links 
Myriad Genetics Moves into Oversold Territory
Print
Share
Myriad Genetics Inc’s (MYGN) share price has entered into oversold territory with a stochastic value of 14.75. The Zacks #2 Rank (“Buy”) stock has either met or topped the consensus estimate in each of the last 4 quarters with an average surprise of 275.68%, or 32 cents per share. Moreover, analysts have been increasing their full-year earnings estimates, with the consensus up 8 cents over the past 30 days to 93 cents per share.
Loading Stories...
More Zacks Resources
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
More Zacks Links
| Market Summary | Feb 10, 2012 08:44 am ET |
0.00
Partner Center